![Jeremy Morgan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeremy Morgan
Directeur/Membre du Conseil chez ARECOR THERAPEUTICS PLC
Postes actifs de Jeremy Morgan
Sociétés | Poste | Début | Fin |
---|---|---|---|
ARECOR THERAPEUTICS PLC | Directeur/Membre du Conseil | - | - |
Independent Dir/Board Member | - | - | |
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Corporate Officer/Principal | - | - |
Historique de carrière de Jeremy Morgan
Anciens postes connus de Jeremy Morgan
Sociétés | Poste | Début | Fin |
---|---|---|---|
PHMR Ltd.
![]() PHMR Ltd. Information Technology ServicesTechnology Services Part of UDG Healthcare Ltd. (Dublin), PHMR Ltd. is a healthcare consulting British company that specializes in insight-enabled pricing and market access approaches to ensure successful product launch and life-cycle management. The company is based in London, UK. The company helps its clients in the healthcare industries build value for their products by using academically-proven analytical methods to find and form clinical, economic, and humanistic evidence. PHMR is an international team of highly qualified health economists and research scientists. The company was founded by Mark Ratcliffe, who has been the CEO since incorporation. PHMR was acquired by UDG Healthcare Ltd. (Dublin) on January 26, 2021 for $43.75 million. | Président | 01/01/2019 | 01/01/2020 |
Directeur des opérations | 01/01/2018 | 01/01/2019 | |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2014 | 01/01/2017 |
Formation de Jeremy Morgan
Coventry University | Undergraduate Degree |
Statistiques
Internationale
Royaume-Uni | 5 |
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ARECOR THERAPEUTICS PLC | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Entreprise privées | 2 |
---|---|
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
PHMR Ltd.
![]() PHMR Ltd. Information Technology ServicesTechnology Services Part of UDG Healthcare Ltd. (Dublin), PHMR Ltd. is a healthcare consulting British company that specializes in insight-enabled pricing and market access approaches to ensure successful product launch and life-cycle management. The company is based in London, UK. The company helps its clients in the healthcare industries build value for their products by using academically-proven analytical methods to find and form clinical, economic, and humanistic evidence. PHMR is an international team of highly qualified health economists and research scientists. The company was founded by Mark Ratcliffe, who has been the CEO since incorporation. PHMR was acquired by UDG Healthcare Ltd. (Dublin) on January 26, 2021 for $43.75 million. | Technology Services |
- Bourse
- Insiders
- Jeremy Morgan
- Expérience